NL123037C - - Google Patents
Info
- Publication number
- NL123037C NL123037C NL123037DA NL123037C NL 123037 C NL123037 C NL 123037C NL 123037D A NL123037D A NL 123037DA NL 123037 C NL123037 C NL 123037C
- Authority
- NL
- Netherlands
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE1963B0073766 DE1445505B2 (de) | 1963-10-04 | 1963-10-04 | Im phenylkern substituierte 2-phenylamino-1,3-diazacyclopentene-(2) |
DEB0077922 | 1964-07-31 | ||
DEB0077921 | 1964-07-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
NL123037C true NL123037C (fr) |
Family
ID=27209240
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL123037D NL123037C (fr) | 1963-10-04 |
Country Status (11)
Country | Link |
---|---|
BE (1) | BE653933A (fr) |
BR (1) | BR6463142D0 (fr) |
CH (3) | CH437316A (fr) |
DE (2) | DE1445505B2 (fr) |
DK (2) | DK108364C (fr) |
FI (2) | FI44913C (fr) |
FR (2) | FR1448765A (fr) |
GB (1) | GB1034938A (fr) |
IL (1) | IL22186A (fr) |
NL (1) | NL123037C (fr) |
SE (2) | SE313310B (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1545628A1 (de) * | 1965-10-01 | 1970-06-25 | Boehringer Sohn Ingelheim | Verfahren zur Herstellung von blutdrucksenkend und sedativ wirksamen Derivaten des 2-(2-Halogenanilino)-1,3-diazacyclopentens-(2) |
BE754832A (fr) * | 1969-08-14 | 1971-02-15 | Beecham Group Ltd | Iminazolines |
US4125620A (en) | 1974-10-01 | 1978-11-14 | Boehringer Ingelheim Gmbh | 2-[(2',6'-Disubstituted-phenyl)-imino]-imidazolidines and salts thereof |
MTP837B (en) | 1977-11-07 | 1979-10-22 | Hoffman La Roche And Co Aktien | Derivatives 2 finino-imidazolidire |
DE2806811A1 (de) * | 1978-02-17 | 1979-08-23 | Boehringer Sohn Ingelheim | Neue substituierte 2-phenylimino- imidazolidine, deren saeureadditionssalze, diese enthaltene arzneimittel und verfahren zur herstellung derselben |
DE2854659A1 (de) * | 1978-12-18 | 1980-07-10 | Boehringer Sohn Ingelheim | Neue 3,4-disubstituierte 2-phenylimino-imidazolidine, deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zu deren herstellung |
CA1175434A (fr) | 1980-09-10 | 1984-10-02 | Hoffmann-La Roche Limited | Derives de ¬(2-phenylamino-1-imidazolidinyloxy) methyl|pyridine 1-oxyde |
US4444782A (en) * | 1982-12-23 | 1984-04-24 | Smithkline Beckman Corporation | 2(4-tert.-Butyl-2,6-dichlorophenyl-imino)imidazolidine and use as an anti-hypertension agent |
-
0
- NL NL123037D patent/NL123037C/xx active
-
1963
- 1963-10-04 DE DE1963B0073766 patent/DE1445505B2/de active Granted
-
1964
- 1964-07-31 DE DE19641445538 patent/DE1445538A1/de active Pending
- 1964-09-14 CH CH1193264A patent/CH437316A/de unknown
- 1964-09-14 CH CH1193164A patent/CH451169A/de unknown
- 1964-09-14 CH CH1189367A patent/CH451172A/de unknown
- 1964-09-16 SE SE1110764A patent/SE313310B/xx unknown
- 1964-09-16 SE SE1071068A patent/SE353721B/xx unknown
- 1964-09-23 FI FI201764A patent/FI44913C/fi active
- 1964-09-28 GB GB39420/64A patent/GB1034938A/en not_active Expired
- 1964-10-01 FR FR990057A patent/FR1448765A/fr not_active Expired
- 1964-10-01 FR FR990056A patent/FR3968M/fr not_active Expired
- 1964-10-02 DK DK486964A patent/DK108364C/da active
- 1964-10-02 BE BE653933D patent/BE653933A/xx unknown
- 1964-10-02 BR BR16314264A patent/BR6463142D0/pt unknown
- 1964-10-04 IL IL2218664A patent/IL22186A/xx unknown
-
1965
- 1965-09-20 DK DK482765A patent/DK117000B/da unknown
-
1971
- 1971-09-17 FI FI260071A patent/FI49614C/fi active
Also Published As
Publication number | Publication date |
---|---|
SE313310B (fr) | 1969-08-11 |
SE353721B (fr) | 1973-02-12 |
BE653933A (fr) | 1965-04-02 |
FI44913C (fi) | 1972-02-10 |
FI49614C (fi) | 1975-08-11 |
FR3968M (fr) | 1966-02-28 |
DE1445538A1 (de) | 1969-02-20 |
CH437316A (de) | 1967-06-15 |
DE1445505B2 (de) | 1976-12-16 |
IL22186A (en) | 1968-06-20 |
CH451172A (de) | 1968-05-15 |
DK117000B (da) | 1970-03-09 |
DK108364C (da) | 1967-11-27 |
BR6463142D0 (pt) | 1973-07-19 |
DE1445505A1 (de) | 1969-10-02 |
GB1034938A (en) | 1966-07-06 |
CH451169A (de) | 1968-05-15 |
FI49614B (fr) | 1975-04-30 |
FR1448765A (fr) | 1966-03-18 |
FI44913B (fr) | 1971-11-01 |